Amgen's GAAP net income for 9 months of 2022 was $4.936 billion, up 23.6% from $3.994 billion in the previous year. Revenue increased 1.8% to $19.484 billion from $19.133 billion a year earlier.
Amgen's GAAP net income for 9 months of 2022 was $4.936 billion, up 23.6% from $3.994 billion in the previous year. Revenue increased 1.8% to $19.484 billion from $19.133 billion a year earlier. 
investors.amgen.com
English (US) 